WordNet

a ketone that forms the nucleus of certain natural yellow pigments like riboflavin

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アマトキシンを含むきのこ中毒（タマゴテングダケなど）：臨床症状、診断、治療 amatoxin containing mushroom poisoning eg amanita phalloides clinical manifestations diagnosis and treatment
2. 筋肉におけるエネルギー代謝 energy metabolism in muscle
3. ハーブ含有アリストロキン酸（AA）誘発性腎症 nephropathy induced by aristolochic acid aa containing herbs
4. 水溶性ビタミンの概要 overview of water soluble vitamins
5. ヘキソースリン酸側路およびグルタチオン代謝疾患（グルコース-6-リン酸脱水素酵素欠損症を除く） disorders of the hexose monophosphate shunt and glutathione metabolism other than glucose 6 phosphate dehydrogenase deficiency

Two Structures of an N-Hydroxylating Flavoprotein Monooxygenase: ORNITHINE HYDROXYLASE FROM PSEUDOMONAS AERUGINOSA.

Olucha J, Meneely KM, Chilton AS, Lamb AL.SourceFrom the Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045.
The Journal of biological chemistry.J Biol Chem.2011 Sep 9;286(36):31789-98. Epub 2011 Jul 13.
The ornithine hydroxylase from Pseudomonas aeruginosa (PvdA) catalyzes the FAD-dependent hydroxylation of the side chain amine of ornithine, which is subsequently formylated to generate the iron-chelating hydroxamates of the siderophore pyoverdin. PvdA belongs to the class B flavoprotein monooxygena
PMID 21757711

Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.

Fedejko-Kap B, Niemira M, Radominska-Pandya A, Mazerska Z.SourceDepartment of Pharmaceutical Technology and Biochemistry, Chemical Faculty, Gda?sk University of Technology , Gda?sk , Poland.
Xenobiotica; the fate of foreign compounds in biological systems.Xenobiotica.2011 Aug 23. [Epub ahead of print]
5-Dimethylaminopropylamino-8-hydroxytriazoloacridinone, C-1305, being the close structural analogue of the clinically tested imidazoacridinone anti-tumour agent, C-1311, expressed high activity against experimental tumours and is expected to have more advantageous pharmacological properties than C-1
PMID 21859392